Simplex Trading
PPBT

Simplex Trading’s Purple Biotech PPBT Stock Holding History

Simplex Trading’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168 Buy
+100
New +$337 ﹤0.01% 9069
2025
Q1 		– Sell
-90
Closed -$4K – 9400
2024
Q4 		$4K Buy
+90
New +$3.46K ﹤0.01% 7776
2023
Q2 		– Sell
-50
Closed -$17K – 9724
2023
Q1 		$17K Sell
50
-116
-70% -$43.5K ﹤0.01% 7081
2022
Q4 		$45K Buy
166
+88
+113% +$33.8K ﹤0.01% 6013
2022
Q3 		$31K Buy
+78
New +$36.5K ﹤0.01% 7035
2022
Q2 		– Sell
-35
Closed -$27K – 10844
2022
Q1 		$27K Sell
35
-295
-89% -$190K ﹤0.01% 7902
2021
Q4 		$256K Buy
330
+216
+189% +$184K ﹤0.01% 4809
2021
Q3 		$111K Buy
114
+1
+0.9% +$969 ﹤0.01% 6469
2021
Q2 		$110K Buy
113
+112
+11,200% +$103K ﹤0.01% 6594
2021
Q1 		$43K Buy
+1
New +$933 ﹤0.01% 6783

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Simplex Trading's PPBT Position: Q2 2026 in Review

Simplex Trading sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 597 shares — an estimated $2.01K sold.

Simplex Trading first reported a position in PPBT in Q4 2020 and held it in 13 quarters. The position peaked at $34K in Q1 2023. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Simplex Trading reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 597 Purple Biotech shares in Q2 2026, an estimated $2.01K.
  • Simplex Trading first reported a position in Purple Biotech in Q4 2020 and held it in 13 quarters.
  • Simplex Trading's Purple Biotech position peaked at $34K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.